Active Pharmaceutical Ingredients (APIs) Revenue to Grow 5.9 % Annually Through 2015

This report provides a detailed insight into the global Active Pharmaceutical Ingredients (APIs) market.

Rockville, MD, October 29, 2010 --( has announced the addition of GBI Research’s new report “Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth” to their collection of Research & Development market reports. For more information, visit

Due to the impact of the economic slowdown, the global API market’s growth has slowed down in the past two years. However, the worst is thought to be over for the pharmaceutical industry. The API market globally will witness significant growth in the next five years. The growth rates will be much higher in the developing countries such as China, India and Brazil than in the mature markets of the US, Germany and Italy.

The strong growth in the generic drugs segment may enable the global API market to grow. The growing incidence of diseases more prevalent in the elderly and lifestyle diseases worldwide will sustain the global API market’s growth rates. The global API market is expected to grow at a CAGR of 5.9% from 2010 to 2015.

The global API market is dominated by synthetic APIs. The share of biotechnology APIs is small as the use of biotechnology in the pharmaceutical industry is a relatively new trend. With the growth in the biotechnology industry worldwide, the use of biological molecules in the pharmaceutical industry is growing. The increasing complexity of diseases also favours the growing trend demand of biotech drugs. Hence, the share of biotech APIs will increase significantly in the coming years.

Generics are increasing their market share in the global API market as many innovator drugs are losing their patents in the regulated markets. Also, due to the impact of the global economic slowdown, the focus on innovation has reduced, giving way to the growth of generics. Generic drugs are also increasingly preferred because of their lower cost in comparison to the highly expensive innovator drugs. As a part of cost containment measures, the governments of many countries are encouraging the generic sector. Due to the emergence of a large number of generic API-producing companies and innovator companies venturing into the generic market, the generic sector API is set for high growth.

North America has historically had the world’s most highly developed and advanced healthcare industry and the pharmaceutical spending in this region is the highest in the world. North America continues to be the world’s largest API market. This is followed by the European region. The API markets in North America and Europe are mature and hence have slower growth rates than markets in the other regions. These two regions have been hit hardest by the economic slowdown. The relative size of the API markets in these regions will reduce in the years to come.

This report provides a detailed insight into the global Active Pharmaceutical Ingredients (APIs) market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in major regions of the world. The report contains market forecasts, product type analysis, drivers and restraints, analysis of the therapeutic categories and a market share analysis of the major producers in the important geographical markets of the world. In addition, it includes market forecasts, product type analysis and therapeutic categories analysis of the APIs in major countries of the world.

For more information, visit

Veronica Franco

Veronica Franco